Blocking IDO1 Helps Shrink Bladder, Cervical Tumors [News in Brief]

Findings from a phase I/IIa study indicate that combining the investigational indoleamine 2,3-dioxygenase 1 inhibitor BMS-986205 with nivolumab is safe and boosts response rates among patients with bladder and cervical cancers.

http://ift.tt/2CR5PeD